The GSEV board was elected on 06 March 2025 at the IGLD meeting in Frankfurt/Main.
Dr. Kerstin Menck
President
Kerstin Menck is a junior research group leader at the University of Münster. Her research is focused on understanding the biogenesis and function of EVs in cancer in order to develop novel biomarkers and therapeutics.
Dr. Christian Preußer
Executive secretary
Christian Preußer is head of the EV Core Facility at the Philipps University Marburg, where he is involved in a wide range of EV-related topics. His own research is focused on the biochemical characterization of EVs in cancer.
Prof. Dr. Julia Groß
Board member (public relations)
Julia Groß is a professor of biochemistry and prorector of research at the private Health and Medical university in Potsdam. She serves as editor in Chief of the annual GSEV journal „Trillium Extracellular Vesicles“. Her research focuses on the biology of EVs and their roles in cell signaling, protein regulation and Wnt signaling.
Tobias Tertel
Board member (public relations)
Tobias Tertel is a researcher at the University Hospital Essen, deeply immersed in the study of EVs, particularly their characterization using imaging flow cytometry. With an ambition to bridge the gap between research and clinical applications, he is also paving the way for introducing MSC-derived EVs into therapeutic settings.
Prof. Dr. Janis Müller
Vice-president
Janis Müller is junior professor for virology at the Philipps University Marburg. He is fascinated by the overlap of EV and virus biology and studies how EVs in body fluids interfere with viral infection and transmission.
Prof. Dr. Michael Pfaffl
Board member (treasurer)
Michael Pfaffl is adjunct professor for animal physiology and immunology at the TUM school of life sciences. His team performs biomarker research and develops tools for analysis of EV-associated nucleic acids. He serves as treasurer in the GSEV board since 2019.
Dr. Daniel Bachurski
Board member (public relations)
Daniel Bachurski is a physician-scientist at the Department I of Internal Medicine at the University of Cologne. His research is focused on elucidating the role of chronic lymphocytic leukemia-derived EVs in the tumor microenvironment by developing single-cell methods to analyze EV recipients.
Prof. Dr. Claudia Günther
Board member
Claudia Günther is professor for Gastrointestinal Pathophysiology at the University Hospital Erlangen. Her research focuses on EVs in organ communication, with a particular emphasis on bacterial EVs and their role in systemic inflammation and tissue regeneration in chronic inflammatory diseases. She investigates the gut vesiculome as a key mediator of host-microbiome interactions, exploring how bacterial EVs influence disease progression and developing novel therapeutic strategies to target systemic disease mechanisms.